Lyell Immunopharma, Inc. (Lyell) announced that dosing has begun for patients with aggressive large B-cell lymphoma in a groundbreaking Phase 3 clinical trial.

Boeing's recent defense contract signed with Israel is not related to the current joint airstrike operations by the United States and Israel against Iran.

Shoulder Innovations recently released its performance outlook, expecting full-year net revenue for fiscal year 2026 to be between $62 million and $65 million.

According to industry sources, US oil giant Chevron and UK energy company Shell are close to finalizing the first major oil production agreements since the US imposed sanctions on Venezuelan President Maduro.

ClearSign Combustion Corporation (NASDAQ: CLIR) recently filed documents with the U.S. Securities and Exchange Commission, officially announcing a reverse stock split plan at a ratio of 1-for-10.